Nalaganje...

Cobimetinib‐induced “dropped head syndrome” and subsequent disease management in an Erdheim‐Chester patient

Our rechallenge of cobimetinib in an Erdheim‐Chester Disease (ECD) patient for the rare adverse effect, “dropped head syndrome,” with a previously unexplored cobimetinib regimen was successful. Similar to other experiences with targeted agents in ECD, dosing of cobimetinib may vary to mitigate toxic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Case Rep
Main Authors: King, Amber C., Diamond, Eli L., Orozco, Jennifer S., Morse, Hannah R., Ouyang, Linda L., Schöder, Heiko, Rampal, Raajit K.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6787838/
https://ncbi.nlm.nih.gov/pubmed/31624624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2297
Oznake: Označite
Brez oznak, prvi označite!